Pharma CMO: Current Market Landscape and Future Opportunities
The present pipeline of pharmaceutical products is becoming increasingly complex and requires specialized facilities, equipment and operational expertise. In addition, the costs associated with acquiring manufacturing capabilities are exorbitant and, therefore, it is difficult for companies with limited finances and capacity constraints to succeed by themselves. Over the years, the pharmaceutical contract manufacturing (Pharma CMO) market has grown into a prominent and promising segment of the overall pharmaceutical industry. In fact, post 2000, more than 150 new Pharma CMO players have been established, offering cost-efficient solutions to several stakeholders in the industry.
Discussions with several industry stakeholders not only confirm the present importance of pharma CMO but also highlight the value likely to be created by them in the long term.
The contract services market landscape, featuring the presence of over 500 companies, is highly fragmented; a number of players have both API and FDF manufacturing capability
Several large-sized pharma CMO players offer services across all scales of operation; most popular packaging formats include tablets / capsules / blisters and vials / cartridges
Interestingly, despite the stringent regulatory standards, a significant proportion of pharma CMO players have procured operational approvals and certifications from the USFDA.
The current installed contract manufacturing capacity is over 100 million liters; this capacity is spread across different regions worldwide.
Driven by an increasing global demand for small molecule drugs, pharmaceutical contract manufacturing market is currently a multi-billion dollar and steadily growing industry.
Within APIs, generic drugs will continue to represent the major focus; in the case of FDFs, the future growth is expected to be driven by injectables.
A closer look at the market landscape reveals a well distributed opportunity in terms of various primary packaging forms, scale of operations and size of manufacturers
To learn more, please click Pharma CMO market. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com. You can also download the SAMPLE REPORT on Pharma CMO by Roots Analysis.
Our Social Media Platform
Web: https://www.rootsanalysis.com/
ANTIBODY DRUG CONJUGATES: THE RECENT APPROVALS
ADC Manufacturing: How Are the Contract Manufacturers Supporting the Growing Demand
Applications of Blockchain in Various Sectors: An Introduction
About Author
Arun_Gupta
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.